Skip to main content
Log in

The role of glucagon in the gastric hyperdynamic circulation of cirrhotic portal hypertensive rats

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The role of glucagon as a mediator of gastric hyperdynamic circulation, induced by carbon tetrachloride (CCl4), was assessed in cirrhotic rats. A selective elimination of pancreatic glucagon from the circulation was achieved by the intravenous infusion of a glucagon antiserum. Gastric blood flow was measured by laser-Doppler flowmetry. The glucagon antiserum had no effect on the blood flow in the stomach in control rats, while in cirrhotic portal hypertensive rats, the glucagon antiserum significantly reduced gastric blood flow (30%). The glucagon antiserum did not completely exclude the gastric hyperdynamic state in the cirrhotic rats. It would thus appear that glucagon contributes to a portion of the gastric hyperdynamic circulation associated with cirrhotic portal hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kotelanski B, Groszmann R, Cohn JN (1972) Circulation times in the splanchnic and hepatic beds in alcoholic liver disease. Gastroenterology 63:102–111

    Google Scholar 

  2. Witte CL, Witte MH, Krone CL (1972) Contrasting hemodynamic patterns of portal hypertension. Ann Surg 176:68–79

    Google Scholar 

  3. Lebrec D, Bataille C, Bercoff E, Valla D (1983) Hemodynamic changes in patients with portal venous obstruction. Hepatology 3:550–553

    Google Scholar 

  4. Vorobioff J, Bredfeldt JE, Groszmann RJ (1983) Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 244:G52-G57

    Google Scholar 

  5. Vorobioff J, Bredfeldt JE, Groszmann RJ (1984) Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 87:1120–1126

    Google Scholar 

  6. Sikuler E, Kravetz D, Groszmann RJ (1985) Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 248:G618-G625

    Google Scholar 

  7. Kitano S, Inokuchi K, Sugimachi K, Koyanagi N (1981) Hemodynamic and morphological changes in the stomach of portal hypertensive rats. Eur Surg Res 13:227–235

    Google Scholar 

  8. Sakata H, Inokuchi K, Nagamine K, Koyanagi N (1985) Esophageal varices produced in dogs. Jpn J Surg 15:81–88

    Google Scholar 

  9. Nagamine K, Inokuchi K, Sakata H, Beppu K, Koyanagi N, Sugimachi K (1986) Development of erosive gastritis in a canine model of esophageal varices. Jpn J Surg 16:218–224

    Google Scholar 

  10. Koyanagi N, Inokuchi K, Nakayama S, Sakata H, Beppu K (1981) Decreased arteriovenous flow resistance in the left gastric venous area in cirrhotic patients. Eur J Clin Invest 11:355–359

    Google Scholar 

  11. Hashizume M, Tanaka K, Inokuchi K (1983) Morphology of gastric microcirculation in cirrhosis. Hepatology 3:1008–1012

    Google Scholar 

  12. Inokuchi K, Beppu K, Koyanagi N, Nagamine K, Hashizume M, Iwanaga T, Sugimachi K (1984) Fifteen years' experience with left gastric venous caval shunt for esophageal varices. World J Surg 8:716–721

    Google Scholar 

  13. Benoit JN, Zimmerman B, Premen AJ, Go VLW, Granger DN (1986) Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol 251:G674-G677

    Google Scholar 

  14. Ahn H, Lindhagen J, Nilsson GE, Salerud EG, Jodal M, Lundgren O (1985) Evaluation of laser-Doppler flowmetry in the assessment of intestinal blood flow in cat. Gastroenterology 88:951–957

    Google Scholar 

  15. Shepherd AP, Riedel GL, Kiel JW, Haumschild DJ, Maxwell LC (1987) Evaluation of an infrared laser-Doppler blood flow-meter. Am J Physiol 252:G832-G839

    Google Scholar 

  16. Imagawa K, Nishino T, Shin S, Uehira S, Hashimura E, Yanaihara C, Yanaihara N (1979) Production of antiglucagon sera with a C-terminal fragment of pancreatic glucagon. Endocrinol Jpn 26:123–131

    Google Scholar 

  17. Benoit JN, Womack WA, Hernandez L, Granger DN (1985) “Forward” and “backward” flow mechanisms of portal hypertension. Gastroenterology 89:1092–1096

    Google Scholar 

  18. Kvietys PR, Shepherd AP, Granger DN (1985) Laser-Doppler, H2 clearance, and microsphere estimates of mucosal blood flow. Am J Physiol 249:G221-G227

    Google Scholar 

  19. Kiel JW, Pitts V, Benoit JN, Granger DN, Shepherd AP (1985) Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats. Am J Physiol 248:G192-G195

    Google Scholar 

  20. Hamilton G, Phing RCF, Hutton RA, Dandona P, Hobbs KEF (1982) The relationship between prostacyclin activity and pressure in the portal vein. Hepatology 2:236–242

    Google Scholar 

  21. Bruix J, Bosch J, Kravetz D, Mastai R, Rodes J (1985) Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology 88:430–435

    Google Scholar 

  22. Sitzmann JV, Bulkley GB, Mitchell MC, Campbell K (1989) Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension. Ann Surg 209:322–327

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshida, T., Kitano, S., Kobayashi, M. et al. The role of glucagon in the gastric hyperdynamic circulation of cirrhotic portal hypertensive rats. Surg Today 25, 906–910 (1995). https://doi.org/10.1007/BF00311757

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00311757

Key Words

Navigation